Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?

Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). However, despite its efficacy and affordability, additional DMARDs or biologic agents are often required in order to achieve the recommended goals of low disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Halilova, Karina I., Brown, Elizabeth E., Morgan, Sarah L., Bridges, S. Louis, Hwang, Min-Ho, Arnett, Donna K., Danila, Maria I.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400362/
https://ncbi.nlm.nih.gov/pubmed/22844292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/978396
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados